Latest Safety News

Pure Hydrogen Corporation has secured a 48-month distribution agreement with Argentina's FRN Enterprise to advance hydrogen and electric vehicle sales across South America, targeting US$20 million in revenue.

RocketDNA has secured an 18-month contract with Vault Minerals to provide advanced aerial data services at the King of the Hills gold operation, integrating its latest autonomous drone technology and automated data processing.

First Graphene Limited is progressing two major projects in hydrogen storage and aerospace 3D printing, backed by multi-million-dollar UK grants to commercialise graphene-enhanced technologies.

Horseshoe Metals has secured crucial Direct Shipping Ore mining approval for its Horseshoe Lights Copper-Gold Project, setting the stage for imminent production and early revenue generation from high-grade copper stockpiles.

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

Prescient Therapeutics has launched a $7 million Share Purchase Plan at a notable discount to fund the next phase of clinical trials for its promising PTX-100 cancer therapy. The capital raise aims to accelerate progress toward regulatory approval and patient access.

HMC Capital has delayed the Neoen VIC Portfolio acquisition settlement by one month, secured a $200 million mezzanine financing facility, and announced a strategic merger of its renewable energy platforms under new leadership.

SenSen Networks has successfully completed a key contract with Montréal’s Agence de mobilité durable, driving record full-year revenue growth exceeding 20%. The company anticipates strong cash collections into FY26, underscoring its expanding global footprint in AI-driven urban management.

Gibb River Diamonds advances key permits for its Edjudina Gold Project, aiming to begin mining at the Neta Prospect by August 2025 with minimal financial risk.

Actinogen Medical has enrolled its 100th participant in the XanaMIA phase 2b/3 Alzheimer’s trial, setting the stage for a critical interim analysis in January 2026 and final results by year-end.

Dimerix Limited has received a significant milestone payment from its Japanese partner FUSO Pharmaceutical, marking progress in the Phase 3 clinical trial of DMX-200 for kidney disease. This payment underscores the growing momentum behind Dimerix’s global licensing strategy.